Palantir Technologies’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Palantir Technologies’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-700,000	Closed	-$179K	–	12
2023 Q1	$179K	Sell	700,000 -300,000	-30%	-$271K	1.14%	9
2022 Q4	$1.18M	Hold	1,000,000	–	–	3.54%	8
2022 Q3	$2.04M	Hold	1,000,000	–	–	3.62%	10
2022 Q2	$1.54M	Hold	1,000,000	–	–	1.58%	15
2022 Q1	$5.05M	Hold	1,000,000	–	–	2.06%	16
2021 Q4	$6.2M	Buy	+1,000,000	New	+$8.93M	2.81%	12

Palantir Technologies's PEAR Position: Q2 2023 in Review

Palantir Technologies sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 700,000 shares — an estimated $179K sold.

Palantir Technologies first reported a position in PEAR in Q4 2021 and held it in 6 quarters. The position peaked at $6.2M in Q4 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Palantir Technologies reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Palantir Technologies sold 700,000 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $179K.
Palantir Technologies first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Palantir Technologies's Pear Therapeutics, Inc. Class A Common Stock position peaked at $6.2M in Q4 2021.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Palantir Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.